NCT05280782View on ClinicalTrials.gov

Development and Translation of Generator-Produced PET Tracer for Myocardial Perfusion Imaging-Dosimetry Group

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 5, 2022

Primary Completion Date

May 1, 2022

Study Completion Date

May 1, 2022

Conditions
Coronary Artery Disease
Interventions
DRUG

Ga-68 Galmydar

Single intravenous injection of the PET radiotracer 68Ga-Galmydar.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Washington University School of Medicine

OTHER

NCT05280782 - Development and Translation of Generator-Produced PET Tracer for Myocardial Perfusion Imaging-Dosimetry Group | Biotech Hunter | Biotech Hunter